Fig. 1 · Structure
Documents & Downloads
Tivanisiran sodium
Cat. No.
A68707
CAS
1848239-71-3
TRPV1 siRNA
Tivanisiran sodium is a small interfering RNA (siRNA) that targets the mRNA of transient receptor potential vanilloid 1 (TRPV1). It is primarily utilized in the research of dry eye disease by effectively silencing TRPV1 expression, which is involved in pain and sensory signaling. This agent facilitates the exploration of TRPV1's role in ocular conditions, contributing to the development of potential therapeutic strategies for managing dry eye symptoms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1848239-71-3 |
| Applications | TRPV1 siRNA |
| Formula | C361H411N141O262Na36P36 |
| Molecular Weight | 12068.3 (free acid) |
| Synonyms | SYL1001 sodium |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.